Skip to content

Examination of brain function improvement of plasmalogen intake.

Examination of brain function improvement of plasmalogen intake. - The effect of plasmalogen on cognitive functions.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000024751
Enrollment
60
Registered
2016-11-08
Start date
2016-10-10
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adults

Interventions

High dose:8 capsules once a day :Take the capsules with water after meals in the evening. 12 weeks. Middle dose:8 capsules once a day :Take the capsules with water after meals in the evening. 12 weeks

Sponsors

Shiba Palace Clinic
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1 Japanese male and female at the age of 50 to 79 at first observation including screening. 2 A person who feels more forgetful than early life.

Exclusion criteria

Exclusion criteria: 1 A person who possibly shows food allergy symptom. 2 A person who had been treated, hospitalized or operated for stroke, subarachnoid hemorrhage, cerebral infarction, cerebral haemorrhage, brain contusion or head trauma. 3 A person who is alcohol or nicotine addict, or whose dietary habit is extremely irregular. 4 A person with medical history or current illness of hepatic disorder. 5 A person with severe anemia. 6 A person with medical history of epileptic stroke, diabetes, thyroid dysfunction or severe renal dysfunction(hemodialysis, uremia, anuria), or attending the hospital regularly for these disorder. 7 A person who has taken a neuropsychological test at hospital. 8 A person who joins other human clinical study. 9 A person who is routinely taking medicines (e.g. antipsychotic, antianxiety agent, antidepressant, antiparkinson agent, antimanic agent, anticonvulsant, anticoagulant agent) which possibly affects the test results. 10 A person who is routinely taking health foods (supplements effective for antioxidative, blood flow-ameliorating and so on) which possibly affects the test results. 11 A person who is judged inappropriate to join the study by doctor in charge. (Subject who is judged inappropriate during this test is excluded from targets of analysis. In addition, a criterion not in screening criteria is not included in exclusion criteria for screening.) 12 A person who have taken an RBANS test in 3 month before main test schedule.

Design outcomes

Primary

MeasureTime frame
3 month later , evaluation of cognitive functions by RBANS and Cognitrax

Secondary

MeasureTime frame
Measurement of blood pressure and pulse, Blood test,Physical measurement

Countries

Japan

Contacts

Public ContactKo MASUDA

SOUKEN Co., Ltd Management Division

k_masuda@mail.souken-r.com03-5408-1555

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026